Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

340B: A Test Market for Health Care Reform?

Sep 01 2010

• By Michael McCaughan

Related Content

Health Care Reform's Pricing Impact: 340B Purchasers See Initial 10% Decline in Brand Prices

Sep 01 2010

Health Care Reform and the Biopharma Sector: A Complete Tactical Victory

Apr 01 2010

Taking Lumps From Health Care Reform

Jun 01 2010

Additional Topics

Regulation Reimbursement BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window